Menu

GENOME ANALYST ANNOUNCES LAUNCH OF HIGH END GENETIC AND MOLECULAR SERVICES BASED ON MICROAARAY AND NEXT GENERATION SEQUENCING| PGS AND PGD | PREDICTIVE GENETICS | PREVENTIVE GENETICS | CANCER MARKERS | SINGLE AND MULTIPLE SNIP ANALYSIS | BLOOD SCREENING ON RT PCR WITH HIV 1 AND HIV 2 |

Molecular Analyst

Molecular Diagnostics as per our understanding is one of the most important clinical tool that can play most important and precise role in analysis of Biological markers in Genome and Proteome, Individual's genetic code, expression of cells as proteins. The technique is applied to diagnose and monitor disease, detect risk, and decide best suited therapy for individuals. It further open prospects of personalized medicine.

Our tests are very useful and are widely used in Infectious disease, Oncology, Human Leukocyte Antigen (HLA) typing that predicts immune function, Infertility, Coagulation and Pharmacogenomics. We have in-house capacity to conduct widest array of Molecular tests and being dedicated molecular lab we have the capacity and intention to offer best in-class service and international research supported analysis.

Our labs are fully equipped and networked with international experts to conduct any and every molecular analysis with precision and expertise. We are equipped with;

@ NGS

@ RT PCR

@ Flow Cytometer

@ GEL DOC 

@ In house experts and qualified professional in the areas of Bioinformatics, Biotechnology and Medical Science.

Oncology Panel

Oncology remains a challenge but development of Molecular technologies have helped evolution of therapy and  monitoring of disease. Our team in association with global research institutions is working towards development of more proven targets. And the same can be seen in our ever growing list of parameters covering predictive and preventive genetics. 

Some of many parameters covered are;

  • Breast Cancer BCR-ABL Panel (BCR ABL 1 & 2)**
  • Ovarian Cancer
  • Breast Cancer Plus
  • Thyroid cancer
  • Lung Cancer
  • leukemia
  • Basal cell carcinoma
  • Chronic lymphocytic leukemia
  • 270 plus genes Germ-line Cancer Genomic Panel.
  • 170 genes cardio panel.
  • Clinical exome sequencing
  • Whole genome sequencing

For more information please write us for specific brochure at info@genomeanalyst.com

 

 

Prenatal Diagnosis

Prenatal Diagnosis is now safer and precise by utilizing some of the most advanced sequencing techniques. And now the amniotic fluid isn't needed for fetus analysis. The fetal DNA in the mother's blood can be  screened. For neonate and fetus analysis we have targeted module like;

  • Downs Syndrome
  • New Born Screening: Severe combined Immunodeficiency (SCID).
  • 20 million reads on world's most advanced platform.

Community Panel

  • BRCA mutation Analysis
  • Colon and Lung Cancer analysis
  • Cardio-Vascular panel
  • Aneuploidy analysis
  • Exome sequencing

For details mail us at info@genomeanalyst.com

Gene views

29007

Infectious Markers

Infections has always been a challenge to detect and quantify using regular diagnostic technology. But after introduction of molecular technology the entire perception and therapy changed. Today the window period for detection has already reduced to 20% in most of the cases and quantification of infections helps in drug dosage and effect. Some of many parameters covered by us are;

  • MTB (including MDR)
  • HIV
  • HPV
  • HCV
  • Hepatitis B, C and E
  • BK- virus
  • MRSA
  • CMV

For more details and specific needs please mail us at info@genomeanalyst.com

 

Pharmacogenomics

We know but not. This line makes me clear with the fact that today we know the type of infection but the drug action and effect isn't known. And this leads to further damage resulting due to growth in disease condition, side effects of molecule, over dosage and under activity of applied activity. Generally such things are monitored by a doctor in random fashion.

We all look same but we are different and so the effect every thing is different. Pharmacogenomics tries to address effect of drugs w.r.t. genetic constitution of every individual.

We already have mapped many drugs for

  1. Cardio-Vascular disorders
  2. Diabetes
  3. Analgesic and Antibiotics
  4. Immunosuppresion
  5. Gynaecology
  6. Osteiporosis
  7. Anti-Viral drugs
  8. Neurological disorders
  9. Asthma

 

Target Therapy

Targeted therapy is now an essential part of cancer treatment. there are many  molecules already mapped and their activity configured w.r.t. genes and its mutation. And target analysis helps drug activity and disease condition.

 

  • KRAS Mutation analysis: Cetuximab or Pentumumab
  • BCR-ABL quatitative transcript analysis - Imatinib therapy
  • BRAF V600E Analysis: Vemurafinib therapy in melanoma.
  • EML-4 ALK fusion analysis: Crizotinib in non- small cell lung cancer.
  • EGFR Mutation analysis: Erlotinib & Gefitinib in NSCLS
  • PML/RAR alpha fusion analysis.- All-trans-retinoic acid and arsenic trioxide treatment in Acute Myleoid Leukemia.
  • ERBB2 (HER2/NEU) expression analysis: Trastuzumab in breast cancer.